SEC SCHEDULE 13G

Company

Coherus Oncology, Inc.

Filed

August 10, 2017

Accession Number

0000902219-17-000562

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →